New pill aims to cut Parkinson's 'OFF' time in half
Disease control
Ongoing
This study tests an experimental pill, CVN424, in 330 people with Parkinson's disease who experience motor complications (wearing-off episodes). Participants take either a low or high dose of CVN424 or a placebo daily for 12 weeks. The main goal is to see if the drug reduces the …
Phase: PHASE3 • Sponsor: Cerevance • Aim: Disease control
Last updated May 20, 2026 11:57 UTC